Detalles de la búsqueda
1.
Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study.
Br J Haematol
; 182(6): 816-829, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29984830
2.
Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction.
Blood
; 125(12): 1932-5, 2015 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25645353
3.
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
Br J Haematol
; 166(1): 109-17, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24673708
4.
Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.
Blood
; 119(23): 5374-83, 2012 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22498739
5.
The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.
Blood
; 119(1): 7-15, 2012 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22021371
6.
Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation.
Blood
; 118(5): 1231-8, 2011 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-21652683
7.
Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results.
Haematologica
; 97(3): 442-50, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22058209
8.
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial.
Lancet Oncol
; 12(8): 743-52, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21771568
9.
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.
Lancet
; 376(9757): 1989-99, 2010 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21131037
10.
Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen.
Haematologica
; 101(2): e69-71, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26471484
11.
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping.
Blood
; 112(13): 4924-34, 2008 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18805967
12.
Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study.
J Clin Oncol
; 31(20): 2540-7, 2013 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23733781
13.
Nurses' comfort level with emergency interventions in the rural hospital setting.
J Rural Health
; 25(3): 296-302, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19566616
14.
Reply to M. Roschewski et al.
J Clin Oncol
; 32(5): 476-7, 2014 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24419132
Resultados
1 -
14
de 14
1
Próxima >
>>